| 产品名称 | Dorzolamide hydrochloride |
| 产品货号 | Axon 1517 CAS [130693-82-2] MF C10H17ClN2O4S3MW 360.90 Purity: 99% Soluble in water and DMSO Description A carbonic anhydrase inhibitor; antiglaucoma agent, used to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension References Certificates Categories Extra info C Plummer et al. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs. Vet. Ophthalmol. 2006, 9(4), 245–249. S Grover et al. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am. J. Ophthalmol. 2006, 141(5), 850–858. Certificate of Analysis Material Safety Data Sheet Cardiovascular Cell Signaling & Oncology Diabetes & Metabolism Miscellaneous Carbonic Anhydrase EC 4.2.1.1. Carbonic anhydrase inhibitor Chemical name (4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide 4H-Thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride Parent CAS No. [120279-96-1] Order Size Unit Price Stock 10 mg €70.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Dorzolamide hydrochlorideAxon 1517 CAS [130693-82-2] MF C10H17ClN2O4S3
Description
A carbonic anhydrase inhibitor; antiglaucoma agent, used to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension
Carbonic anhydrase inhibitor
Chemical name(4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide 4H-Thieno[2,3-b]thiopyran-2-sulfonamide hydrochloride Parent CAS No.[120279-96-1] |
| 产品资料 |
